| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Ann Thorac Surg 1995;59:1519-1523
© 1995 The Society of Thoracic Surgeons
Departments of Surgery and Clinical Chemistry, Tampere University Hospital, and Department of Biomedical Sciences, University of Tampere, Tampere, Finland
Accepted for publication February 28, 1995.
* Address reprint requests to Dr Sisto, Samoilijankatu 27, 33580 Tampere, Finland.
Oxygen-derived free radicals constitute one part of the etiologic factors for cardiac onset harmful events. Allopurinol is able to reduce the generation of free radicals. Vitamins E and C scavenge radicals after their formation. Eighty-one patients with coronary artery disease were randomized into four study groups: Group 1 (n = 20) patients had stable disease and received oral vitamin E for 4 weeks, and vitamin C and allopurinol 2 days before and 1 day after coronary artery bypass grafting. Group 2 (n = 25) consisted of their controls. Group 3 patients (n = 17) had more unstable disease and received the same medications as group 1, except that vitamin E was given only 2 days before the operation. Group 4 (n = 19) was their controls. Groups 1 and 3 had fewer ischemic electrocardiographic events and required less dopamine perioperatively than corresponding control groups 2 and 4. Group 3 had fewer perioperative infarctions and less creatine kinase-MB release than the respective controls (group 4). Plasma levels of vitamins E and C, urate, and total free radical trapping ability were considered to support the theory about the role of free radicals in reperfusion injury. Especially the unstable patients, but also patients with stable coronary artery disease requiring coronary artery bypass grafting benefit from perioperative allopurinol and vitamin E and C treatment.
This article has been cited by other articles:
|
|
 |
|
  L. Harling, S. Rasoli, J. A. Vecht, H. Ashrafian, A. Kourliouros, and T. Athanasiou Do antioxidant vitamins have an anti-arrhythmic effect following cardiac surgery? A meta-analysis of randomised controlled trials Heart, October 15, 2011; 97(20): 1636 - 1642. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Rasoli, A. Kourliouros, L. Harling, and T. Athanasiou Does prophylactic therapy with antioxidant vitamins have an effect on atrial fibrillation following cardiac surgery? Interact CardioVasc Thorac Surg, June 1, 2011; 13(1): 82 - 85. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. L. Lazar Uric acid levels and outcomes from coronary artery bypass grafting: Is it the chicken or the egg? J. Thorac. Cardiovasc. Surg., July 1, 2009; 138(1): 8 - 8. [Full Text] [PDF]
|
|
|
|
|
|
G. S. Hillis, B. H. Cuthbertson, P. H. Gibson, J. D. McNeilly, G. S. Maclennan, R. R. Jeffrey, K. G. Buchan, H. El-Shafei, G. Gibson, and B. L. Croal Uric acid levels and outcome from coronary artery bypass grafting J. Thorac. Cardiovasc. Surg., July 1, 2009; 138(1): 200 - 205. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. G Raja and G. D Dreyfus Modulation of Systemic Inflammatory Response after Cardiac Surgery Asian Cardiovasc Thorac Ann, December 1, 2005; 13(4): 382 - 395. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. G. Kevin, E. Novalija, and D. F. Stowe Reactive Oxygen Species as Mediators of Cardiac Injury and Protection: The Relevance to Anesthesia Practice Anesth. Analg., November 1, 2005; 101(5): 1275 - 1287. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Tossios, W. Bloch, A. Huebner, M. R. Raji, F. Dodos, O. Klass, M. Suedkamp, S.-M. Kasper, M. Hellmich, and U. Mehlhorn N-acetylcysteine prevents reactive oxygen species-mediated myocardial stress in patients undergoing cardiac surgery: Results of a randomized, double-blind, placebo-controlled clinical trial J. Thorac. Cardiovasc. Surg., November 1, 2003; 126(5): 1513 - 1520. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Lassnigg, A. Punz, R. Barker, P. Keznickl, N. Manhart, E. Roth, and M. Hiesmayr Influence of intravenous vitamin E supplementation in cardiac surgery on oxidative stress: a double-blinded, randomized, controlled study Br. J. Anaesth., February 1, 2003; 90(2): 148 - 154. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Stangl, G. Baumann, K. Stangl, and S. B Felix Negative inotropic mediators released from the heart after myocardial ischaemia-reperfusion Cardiovasc Res, January 1, 2002; 53(1): 12 - 30. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Nakayama, S. Akiyama, M. Inagaki, Y. Gotoh, and K. Oguchi Dehydroascorbic acid and oxidative stress in haemodialysis patients Nephrol. Dial. Transplant., March 1, 2001; 16(3): 574 - 579. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Butler, A. D. Morris, J. J. F. Belch, A. Hill, and A. D. Struthers Allopurinol Normalizes Endothelial Dysfunction in Type 2 Diabetics With Mild Hypertension Hypertension, March 1, 2000; 35(3): 746 - 751. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. L. Early and S. R. Roberts Excellence and low case volume: an example of the inapplicability of volume-based credentialing Ann. Thorac. Surg., January 1, 2000; 69(1): 146 - 150. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. E. Vento, J. Aittomaki, K. A. Verkkala, L. J. Heikkila, J. A. Salo, J. Sipponen, and O. J. Ramo Nitecapone as an additive to crystalloid cardioplegia in patients who had coronary artery bypass grafting Ann. Thorac. Surg., August 1, 1999; 68(2): 413 - 420. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. MINOTTI, G. CAIRO, and E. MONTI Role of iron in anthracycline cardiotoxicity: new tunes for an old song? FASEB J, February 1, 1999; 13(2): 199 - 212. [Abstract] [Full Text]
|
|
|
|
 |
|
 C. C. Tangney, J. S. Hankins, M. A. Murtaugh, and W. Piccione Jr Plasma Vitamins E and C Concentrations of Adult Patients During Cardiopulmonary Bypass J. Am. Coll. Nutr., April 1, 1998; 17(2): 162 - 170. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
